Jay R. Venkatesan - 20 May 2022 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: President and Chief Executive Officer and Director, Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Issuer symbol: ELTX
Transactions as of: 20 May 2022
Net transactions value: +$101,428
Form type: 4
Filing time: 25 May 2022, 17:58:29 UTC
Previous filing: 04 Mar 2022
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$61,500	+50,000	+3.1%	$1.23^*	1,689,257	20 May 2022	Direct
transaction	ELTX	Common Stock	Purchase	$39,928	+32,200	+1.9%	$1.24^*	1,721,457	24 May 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

President and Chief Executive Officer and Director